An2 Therapeutics, Inc. · NASDAQ:ANTX

Almitas Capital LLC reported a 5.20% stake in An2 Therapeutics, Inc. (Schedule 13G)

Event Sep 30, 2025 · Filed Nov 14, 2025

Almitas Capital LLC reported a 5.20% stake in An2 Therapeutics, Inc., 1,428,323 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).

Stake
5.20%
Shares
1,428,323
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Almitas Capital LLC5.20%1,428,323

Source

View original at SEC

Related